featured
TAVI and FFR-Guided PCI vs Conventional Surgical Aortic Valve Replacement and CABG for Patients With Aortic Valve Stenosis and Complex or Multivessel Coronary Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
Lancet 2024 Dec 04;[EPub Ahead of Print], E Kedhi, RS Hermanides, JE Dambrink, SK Singh, JM Ten Berg, D van Ginkel, M Hudec, G Amoroso, IJ Amat-Santos, M Andreas, R Campante Teles, G Bonnet, E Van Belle, L Conradi, L van Garsse, W Wojakowski, V Voudris, J Sacha, P Cervinka, E Lipsic, S Somi, L Nombela-Franco, S Postma, K Piayda, G De Luca, E Kolkman, KP Malinowski, T ModineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.